1326: The visiting preferences of cardiovascular patients

Abstract

(WPW) syndrome (n = 97), mean age 48 years, 48% males were included in the study. Results: There were no significant difference in the healthstate utility score calculated from the five dimensions in EuroQol-5D between the patients with HF 0.73 (0.62-0.85) median, (inter quartile range), and patients with PSVT 0.76 (0.72-0.85) (P = 0.17). However, there were significant differences in two of the dimensions, mobility (P =0.001) and usual activities (P = 0.001) with HF patients having more problems with walking around and performing daily activities. 16% of the HF patients and 30% of the PSVT patients were afraid of dying (P = 0.001). Fear of death and anxiety/depression were significantly correlated in patients with HF (r = 0.40, P = 0.001). No other correlation to fear of death was found among dimensions of EuroQol-5D, utility scores and demographic variables in patients with HF. Fear of death did not correlate with any dimension of EuroQol-5D, the utility score or demographic variables in the patients with PSVT. The PSVT group consisted of another type of cardiac patients that were younger and had a more equal distribution of gender than the patients with HF. It was therefore interesting to compare these two groups. It would have been interesting to also compare with a sample of healthy elderly individuals. Conclusion: There were no significant difference in the perceived health-state between the patients with HF and patients with PSVT. Despite the fact that the patients with PSVT were younger and had a much better prognosis of their cardiac disease they had a significantly higher fear of death than patient with HF. Higher levels of depression and anxiety were correlated to a fear of death in HF, but not in PSVT patients.